Haemonetics Corporation ( HAE) - Stock Earnings
HAE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
HAE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 34.0 million USD | 321.4 million USD |
| 2025Q3 | 38.7 million USD | 327.3 million USD |
| 2025Q4 | 44.7 million USD | 339.0 million USD |
| 2026Q3 Est. | — | — |
HAE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 115.4 million USD | 1.2 billion USD |
| 2024 | 117.6 million USD | 1.3 billion USD |
| 2025 | 167.7 million USD | 1.4 billion USD |
| 2026 Est. | — | — |
HAE
Price: $78.07
Earnings Per Share: 3.63 USD
P/E Ratio: 15.71
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 121503
Ebitda: 23.3 millionMarket Capitalization: 3.4 billion